Angus C. Russell - Dec 13, 2021 Form 4 Insider Report for Revance Therapeutics, Inc. (RVNC)

Role: Director
Signature: /s/ Gordon Ho, Attorney-in-Fact
Stock symbol: RVNC
Transactions as of: Dec 13, 2021
Transactions value $: $100,741
Form type: 4
Date filed: 12/15/2021, 07:17 PM
Previous filing: Aug 12, 2021
Next filing: May 13, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	RVNC	Common Stock	Purchase	$101K	+6.4K	+31.2%	$15.74	26.9K	Dec 13, 2021	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Table 1, Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $15.65 to $15.81. Mr. Russell undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.

Content

The price reported in Table 1, Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $15.65 to $15.81. Mr. Russell undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.